Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

CORT holding history

Corcept Therapeutics Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CORT overviewAll 13F holders of CORTFull Q2 2026 holdings

Shares (Q2 2026)
883,001
Value
$76.8M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CORT by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026883,001$76.8M<0.1%−298,347−25.3%ReducedHolders
Q1 20261,181,348$47.6M<0.1%+1,011,681+596.3%AddedHolders
Q4 2025169,667$5.90M<0.1%−414,431−71.0%ReducedHolders
Q3 2025584,098$48.5M<0.1%−89,039−13.2%ReducedHolders
Q2 2025673,137$49.4M<0.1%−27,127−3.9%ReducedHolders
Q1 2025700,264$80.0M0.1%−186,312−21.0%ReducedHolders
Q4 2024886,576$44.7M<0.1%+98,512+12.5%AddedHolders
Q3 2024788,064$36.5M<0.1%−161,079−17.0%ReducedHolders
Q2 2024949,143$30.8M<0.1%−183,941−16.2%ReducedHolders
Q1 20241,133,084$28.5M<0.1%−525,554−31.7%ReducedHolders
Q4 20231,658,638$53.9M0.1%+140,531+9.3%AddedHolders
Q3 20231,518,107$41.4M0.1%+368,458+32.0%AddedHolders
Q2 20231,149,649$25.6M<0.1%+365,450+46.6%AddedHolders
Q1 2023784,199$17.0M<0.1%−408,159−34.2%ReducedHolders
Q4 20221,192,358$24.2M<0.1%−419,466−26.0%ReducedHolders
Q3 20221,611,824$41.3M0.1%+4040.0%AddedHolders
Q2 20221,611,420$38.3M0.1%+492,709+44.0%AddedHolders
Q1 20221,118,711$25.2M<0.1%+724,963+184.1%AddedHolders
Q4 2021393,748$7.80M<0.1%+168,071+74.5%AddedHolders
Q3 2021225,677$4.44M<0.1%+88,821+64.9%AddedHolders
Q2 2021136,856$3.01M<0.1%−148,261−52.0%ReducedHolders
Q1 2021285,117$6.78M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.